AQEMIA

AQEMIA is a techbio company using generative AI trained on atomic-scale physics to design innovative medicines. Its platform doesn't rely on experimental data, enabling the creation of novel drug candidates. The company has achieved preclinical successes and collaborations with major pharmaceutical firms.

Buy Funded Startups lists

Funding Round:

Funding Amount: $38M

Date: 10-Dec-2024

Investors: Cathay Innovation, Wendel, Bpifrance Large Venture, Eurazeo, Elaia

Markets: Biotech, AI, Drug Discovery

HQ: Paris, Île-de-France, France

Founded: 2019

Website: https://www.aqemia.com

LinkedIn: https://www.linkedin.com/company/aqemia/?originalSubdomain=fr

Twitter: https://twitter.com/aqemia

Instagram: